Fernando Pastor

6PUBLICATIONS
10CO-AUTHORS
Micro-manipulationCancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteinsMolecular targetsMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 16, 2023
Engineering U1-Based Tetracycline-Inducible Riboswitches to Control Gene Expression in Mammals.

Eric Rovira, Beatriz Moreno, Nerea Razquin

|Feb 25, 2023
Modulating T Cell Responses by Targeting CD3.

Ashwathi Puravankara Menon, Beatriz Moreno, Daniel Meraviglia-Crivelli

|Nov 11, 2022
Aptamers, a New Therapeutic Opportunity for the Treatment of Multiple Myeloma.

Ane Amundarain, Fernando Pastor, Felipe Prósper

|Aug 26, 2022
Therapeutic Strategies to Enhance Tumor Antigenicity: Making the Tumor Detectable by the Immune System.

Daniel Meraviglia-Crivelli, Angelina Zheleva, Martin Barainka

|Apr 03, 2021
Oligonucleotide-Based Therapies for Renal Diseases.

Fernando Cartón-García, Cassondra Jeanette Saande, Daniel Meraviglia-Crivelli

|Sep 22, 2017
Identification of LAG3 high affinity aptamers by HT-SELEX and Conserved Motif Accumulation (CMA).

Mario Martínez Soldevilla, Sandra Hervas, Helena Villanueva

Pageof 1